Discussion about this post

User's avatar
Sarah  Hawkins (she/her)'s avatar

I’m interested in an integrated and imaginative approach to treating psychosis and schizophrenia which is free from a world view wedded to one type of approach. I do agree that it includes a mismatch between interior bottom up signals and top down ones. These signals contain hundreds of neurotransmitters and millions of neurons and their glial cells, so it has a chemical level component. It can also be described at the functional or cognitive level (the word cognitive I find very steampunk to be honest with you). Many neuroleptic drugs have helped people live normal lives when they stay on them. These people in recovery then move away from the healthcare system and are no longer labelled as schizophrenic. This creates a smaller and smaller group that can create the illusion that the condition cannot be cured. Most relapses occur when people come off their meds because they feel well and don’t think they need them anymore. Many people who are labelled “treatment resistant” simply aren’t taking the medication and not telling anyone that they aren’t. They behave like this because they don’t trust authority figures. Kindness and compassion are surprisingly effective in these situations. Psychotics respond really well to compassion, even if they are unable to articulate this at the time. Your research sounds really interesting and I urge you to do a study if you are able. For the human and psychological component of recovery, do have a look at some of our blogs on here for a window into our lives as people, not patients ❤️

Expand full comment
Halcyon's avatar

Great find in that Xie article. I've been using tirzepatide extensively in pts on clozapine and anecdotally I see improvement in schizophrenia symptoms as well. Of course to justify to insurance they have to have diabetes, BMI, etc etc, but who on long term clozapine maintenance doesn't have severe metabolic syndrome really. I really want to run a small trial just adding it as an adjunct.

One of the saddest things about prescribing antipsychotics to me is that Im basically taking 15 years off a persons life because of metabolic syndrome. Really excited about the potential of these agents to mitigate that.

Note that if you do start to use the GLP1s the data we do have show tirzepatide is the far more effective agent than semaglutide and with a more favorable side effect profile. I don't use semaglutide anymore and its not because im an eli lilly shill, its because the data are pretty conclusive. Unfortunately I still see a lot of physicians just instinctively going for the semaglutide because it came out first I think.

In general I think your theory is cool but idgaf. Give me a randomized trial, it works or it doesn't regardless of mechanism.

Expand full comment
17 more comments...

No posts